Next‐generation sequencing for BCR‐ABL1 kinase domain mutations in adult patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A position paper

Emergence of clones carrying point mutations in the BCR‐ABL1 kinase domain (KD) is a common mechanism of resistance to tyrosine kinase inhibitor (TKI)‐based therapies in Philadelphia chromosome‐positive (Ph+) acute lymphoblastic leukemia (ALL). Sanger sequencing (SS) is the most frequently used meth...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Med
Prif Awduron: Soverini, Simona, Albano, Francesco, Bassan, Renato, Fabbiano, Francesco, Ferrara, Felicetto, Foà, Robin, Olivieri, Attilio, Rambaldi, Alessandro, Rossi, Giuseppe, Sica, Simona, Specchia, Giorgina, Venditti, Adriano, Barosi, Giovanni, Pane, Fabrizio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2020
Pynciau:
Clinical Cancer Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7196068/
https://ncbi.nlm.nih.gov/pubmed/32154668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2946
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg